PT1373260E - Derivados de dibenzo[c]cromen-6-ona como agentes anticancerígenos - Google Patents

Derivados de dibenzo[c]cromen-6-ona como agentes anticancerígenos Download PDF

Info

Publication number
PT1373260E
PT1373260E PT02701135T PT02701135T PT1373260E PT 1373260 E PT1373260 E PT 1373260E PT 02701135 T PT02701135 T PT 02701135T PT 02701135 T PT02701135 T PT 02701135T PT 1373260 E PT1373260 E PT 1373260E
Authority
PT
Portugal
Prior art keywords
dibenzo
derivatives
chromen
cancer agents
cancer
Prior art date
Application number
PT02701135T
Other languages
English (en)
Inventor
Jonathan Martin Schmidt
Peter Redden
Julie Mercure
Shuguang Zhu
John Whelan
Natalie Lazarowych
Original Assignee
Paloma Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paloma Pharmaceuticals Inc filed Critical Paloma Pharmaceuticals Inc
Publication of PT1373260E publication Critical patent/PT1373260E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/908—Mechanical repair performed/surgical
    • Y10S977/911—Cancer cell destruction
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/908—Mechanical repair performed/surgical
    • Y10S977/912—Cancer cell repair

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT02701135T 2001-02-22 2002-02-21 Derivados de dibenzo[c]cromen-6-ona como agentes anticancerígenos PT1373260E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27019801P 2001-02-22 2001-02-22
US09/934,086 US6632835B2 (en) 2001-02-22 2001-08-21 Dibenzo[c]chromen-6-one derivatives as anti-cancer agents

Publications (1)

Publication Number Publication Date
PT1373260E true PT1373260E (pt) 2008-09-05

Family

ID=26954131

Family Applications (1)

Application Number Title Priority Date Filing Date
PT02701135T PT1373260E (pt) 2001-02-22 2002-02-21 Derivados de dibenzo[c]cromen-6-ona como agentes anticancerígenos

Country Status (11)

Country Link
US (1) US6632835B2 (pt)
EP (1) EP1373260B1 (pt)
AT (1) ATE396989T1 (pt)
AU (1) AU2002234466B2 (pt)
CA (1) CA2438713C (pt)
CY (1) CY1108266T1 (pt)
DE (1) DE60226851D1 (pt)
DK (1) DK1373260T3 (pt)
ES (1) ES2307721T3 (pt)
PT (1) PT1373260E (pt)
WO (1) WO2002066467A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2325223B1 (en) * 2002-10-30 2014-05-14 Sumitomo Chemical Company, Limited Complex aryl copolymer compounds and polymer light emitting devices made by using the same
USRE46558E1 (en) 2005-04-28 2017-09-26 Paloma Pharmaceuticals, Inc. Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis
US20060257337A1 (en) * 2005-04-28 2006-11-16 David Sherris Compositions and methods to treat skin diseases characterized by cellular proliferation and angiogenesis
CA2643579C (en) 2006-02-28 2018-05-15 Paloma Pharmaceuticals, Inc. Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis
CN101431893B (zh) * 2006-02-28 2013-09-04 帕洛马医药公司 治疗具有细胞增殖和血管生成特征的疾病的组合物和方法
CA2719853A1 (en) * 2008-03-25 2009-10-01 Paloma Pharmaceuticals, Inc. Methods of treating fibrotic disorders
US9381187B2 (en) 2011-02-16 2016-07-05 Paloma Pharmaceuticals, Inc. Radiation countermeasure agents
KR101498671B1 (ko) * 2012-02-03 2015-03-06 한국생명공학연구원 신규한 항균성 화합물

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3573327A (en) * 1970-03-23 1971-03-30 Searle & Co 3-(lower alkoxy)-7,8,9,10-tetrahydro-6h-dibenzo-(b,d) pyran-6,9-diones and derivatives thereof
US5268384A (en) 1990-11-21 1993-12-07 Galardy Richard E Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors
GB9603325D0 (en) * 1996-02-16 1996-04-17 Imperial College A compound
US5359134A (en) * 1992-08-14 1994-10-25 Eastman Chemical Company Process for preparing phenylterephthalic acid
US5763441A (en) 1992-11-13 1998-06-09 Sugen, Inc. Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
US5629327A (en) 1993-03-01 1997-05-13 Childrens Hospital Medical Center Corp. Methods and compositions for inhibition of angiogenesis
US5643900A (en) 1993-07-02 1997-07-01 Fotsis; Theodore Method for treatment of pathological conditions associated with angiogenesis and preparation therefor
US5504074A (en) 1993-08-06 1996-04-02 Children's Medical Center Corporation Estrogenic compounds as anti-angiogenic agents
UA32427C2 (uk) 1993-10-15 2000-12-15 Елі Ліллі Енд Компані Застосування бензотіофенів або їх фармацевтично прийнятних солей або сольватів для інгібування ангіогенезу і/або ангіогенних захворювань
US5646136A (en) 1994-01-04 1997-07-08 Duke University Methods of inhibiting angiogenesis and tumor growth, and treating ophthalmologic conditions with angiostatic and therapeutic steroids
US5753230A (en) 1994-03-18 1998-05-19 The Scripps Research Institute Methods and compositions useful for inhibition of angiogenesis
US5639725A (en) 1994-04-26 1997-06-17 Children's Hospital Medical Center Corp. Angiostatin protein
US5843925A (en) 1994-12-13 1998-12-01 American Cyanamid Company Methods for inhibiting angiogenesis, proliferation of endothelial or tumor cells and tumor growth
AU778159B2 (en) * 1999-10-18 2004-11-18 University Of Connecticut, The Peripheral cannabinoid receptor (CB2) selective ligands

Also Published As

Publication number Publication date
US6632835B2 (en) 2003-10-14
DE60226851D1 (de) 2008-07-10
ES2307721T3 (es) 2008-12-01
DK1373260T3 (da) 2008-09-29
WO2002066467A1 (en) 2002-08-29
US20020115711A1 (en) 2002-08-22
ATE396989T1 (de) 2008-06-15
CA2438713C (en) 2011-04-26
EP1373260A1 (en) 2004-01-02
CA2438713A1 (en) 2002-08-29
CY1108266T1 (el) 2014-02-12
EP1373260B1 (en) 2008-05-28
AU2002234466B2 (en) 2006-02-16

Similar Documents

Publication Publication Date Title
CY1108266T1 (el) Παραγωγα διβενζο(c) χρωμεν-6-ονης ως αντικαρκινικοι παραγοντες
IL231810A (en) History of itensinoid and pharmaceutical preparations containing the same methods of preparation and use thereof for cancer treatment
TR200000576T1 (tr) Lipozomal kapsüllenmiş taksan uygulanması için bir yöntem
ME00425B (me) Liječenje sa anti-vegf antitijelima
DE69834923D1 (en) Hochgradig lipophile camptothecin-derivate
UY26082A1 (es) Derivados de 1,4-diazabiciclo [3.2.2] nonan-4-carboxilato y -carboxamidas, su preparacion y su aplicacion en terapeutica
NZ516349A (en) Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease
TW200510367A (en) Novel lapachone compounds, their preparation, and the use thereof
SE0300098D0 (sv) Use of cyclin D1 inhibitors
WO2003106384A3 (en) NOVEL BORIC CHALCONE DERIVATIVES AND USES THEREOF
DE602004017326D1 (de) Tetrahydrocarbazolderivate und deren pharmazeutische verwendung
IL137672A0 (en) Derivatives of branched-chain lipophilic molecules and uses thereof
BR0311866A (pt) Composições de saponinas ou sapogeninas para terapia de câncer
AU2001240909A1 (en) Proteins, genes and their use for diagnosis and treatment of breast cancer
EP1635764A4 (en) CONJUGATE FOR THE SPECIFIC TARGETING OF ANTICANCER AGENTS ON CANCER CELLS AND PRODUCTION OF THE CONJUGATE
ATE199641T1 (de) Terpenderivate (sarcodictyine) als antikrebsmittel
HUP0301433A2 (hu) Antiprogesztinek alkalmazása a sejtek apoptózisának indukálására szolgáló gyógyszerkészítmények előállítására
ATE272642T1 (de) Thieno(2,3-d)pyrimidindione und ihre verwendung als pharmazeutische mittel
MXPA03002494A (es) Metodo para reducir toxicidad de quimio terapias combinadas.
ATE261732T1 (de) Pharmazeutische zusammensetzung, umfassend eukalyptus- und orangenöl
WO2002066451A3 (en) 1,2-diphenyl-1-naphthyl ethene derivatives, analogs and use thereof
AU2001280443A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU2003287834A1 (en) Use of aglycon protopanaxadiol in cancer therapy
AU2001282410A1 (en) N-benzylindole-3-acetic acid derivatives for use in the treatment of drug resistan cancer
AU2003287833A1 (en) Use of aglycon protopanaxatriol in cancer therapy